Enable Medicine provides a cloud‑based platform that consolidates multimodal biological data—such as single‑cell, spatial, omics, imaging, and clinical metadata—into a unified atlas. Using proprietary AI/ML methods, including graph neural networks and spatial deep learning, the platform generates interpretable insights for target identification, biomarker discovery, patient stratification, and trial design, helping biopharma and academic researchers accelerate therapeutic development.
Funding
$60M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
4OFounders
Product
Problem
Biopharma and academic researchers often struggle with fragmented, multimodal biological datasets that are difficult to integrate, analyze, and translate into actionable insights for drug discovery and development. This siloed data hampers efficient target identification, patient stratification, and trial design, increasing risk and time-to-market for new therapeutics.
Solution
Enable Medicine offers an integrated cloud-based data-to-insights platform that consolidates high‑resolution single‑cell, spatial, omics, imaging, and clinical data into a unified biological atlas. The platform combines proprietary AI/ML methods—including graph neural networks, spatially informed analysis, and foundation models—with domain‑expert scientific support to generate interpretable, reproducible insights. Users can query the atlas for mechanisms of action, biomarker discovery, target validation, and patient stratification, receiving interactive reports that trace data lineage and model versions. Advanced search and visualization tools enable deep multimodal exploration, while continuous model updates expand annotation depth over time. The solution accelerates decision‑making across the drug development pipeline, from target identification to clinical trial design.
Target Audience
Primary customers are biopharma companies, biotech firms, and academic research groups that need to integrate and analyze large multimodal datasets to accelerate therapeutic discovery and development.
Features
- Unified cloud repository that ingests and organizes multimodal biological data (genomics, transcriptomics, proteomics, imaging, clinical metadata) across diseases and indications
- Proprietary AI/ML toolkit featuring graph neural networks, spatial deep learning, and foundation models for precise, explainable biological inference
- Interactive insight reports with version tracking, data lineage, and customizable visualizations for transparent analysis
- Advanced search engine supporting queries on mechanisms of action, biomarkers, patient stratification, and indication selection
- Continuous curation of public and private datasets, expanding the biological atlas and enabling future‑proof data management
- Integrated expertise from in‑house domain scientists to guide model selection, benchmarking, and interpretation of results